This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2025
Delivered in a 100% Virtual FormatEastern Daylight Time (EST)
Menu

Prof. Catherine Green
Associate Professor, Head of Clinical Biomanufacturing Facility at University of Oxford
Speaker

Agenda Sessions

  • Development, trial and scale up of the Oxford-AstraZeneca vaccine against COVID-19

    , 13:45
    View Session

At this event

Prev
Next
David K. Robinson, Ph.D.
Deputy Director, CMC Vaccines Development & Surveillance
Bill and Melinda Gates Foundation

See Prof. Catherine at BioProcess International: COVID-19 Therapeutic Development & Production